Inozyme Pharma Correlations

INZY Stock

USD 0.93 0.03 3.57%

The current 90-days correlation between Inozyme Pharma and X4 Pharmaceuticals is 0.19 (i.e., Average diversification). The correlation of Inozyme Pharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Inozyme Pharma Correlation With Market

Modest diversification

The correlation between Inozyme Pharma and DJI is 0.25 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Inozyme Pharma and DJI in the same portfolio, assuming nothing else is changed.

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Inozyme Pharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

For more information on how to buy Inozyme Stock please use our How to Invest in Inozyme Pharma guide.

Moving together with Inozyme Stock

0.86	EYEN	Eyenovia	Pair Corr
0.82	CLDX	Celldex Therapeutics	Pair Corr
0.97	CRNX	Crinetics Pharmaceuticals	Pair Corr
0.65	CRVS	Corvus Pharmaceuticals	Pair Corr
0.62	MDAI	Spectral AI	Pair Corr
0.81	MODD	Modular Medical	Pair Corr
0.78	APYX	Apyx Medical	Pair Corr
0.91	SGHT	Sight Sciences	Pair Corr
0.81	SRDX	SurModics	Pair Corr
0.61	CNMD	CONMED	Pair Corr

Moving against Inozyme Stock

0.82	FNA	Paragon 28	Pair Corr
0.69	CPIX	Cumberland Pharmaceuticals	Pair Corr
0.63	CMRX	Chimerix Sell-off Trend	Pair Corr
0.44	OPT	Opthea	Pair Corr
0.86	NVRO	Nevro Corp	Pair Corr
0.85	NYXH	Nyxoah	Pair Corr
0.71	LUCD	Lucid Diagnostics Buyout Trend	Pair Corr
0.63	KIDS	Orthopediatrics Corp	Pair Corr
0.46	LUNG	Pulmonx Corp	Pair Corr
0.45	INMD	InMode	Pair Corr
0.38	NPCE	Neuropace	Pair Corr
0.83	TOI	Oncology Institute Earnings Call This Week	Pair Corr
0.72	BRK-A	Berkshire Hathaway	Pair Corr
0.72	BRK-B	Berkshire Hathaway	Pair Corr
0.69	TMCI	Treace Medical Concepts	Pair Corr
0.69	FWEDF	Fireweed Zinc	Pair Corr
0.68	SWZNF	Schweizerische Nationalbank	Pair Corr

Related Correlations Analysis

	DAWN	XFOR	ABOS	MREO	TERN	PDSB	HOOK	ELDN	AMLX
DAWN		0.8	0.76	0.73	0.72	0.7	0.93	0.78	0.34	DAWN
XFOR	0.8		0.82	0.87	0.83	0.84	0.76	0.66	0.54	XFOR
ABOS	0.76	0.82		0.89	0.93	0.9	0.81	0.48	0.68	ABOS
MREO	0.73	0.87	0.89		0.9	0.82	0.72	0.5	0.67	MREO
TERN	0.72	0.83	0.93	0.9		0.89	0.76	0.47	0.7	TERN
PDSB	0.7	0.84	0.9	0.82	0.89		0.74	0.59	0.71	PDSB
HOOK	0.93	0.76	0.81	0.72	0.76	0.74		0.71	0.34	HOOK
ELDN	0.78	0.66	0.48	0.5	0.47	0.59	0.71		0.27	ELDN
AMLX	0.34	0.54	0.68	0.67	0.7	0.71	0.34	0.27		AMLX
	DAWN	XFOR	ABOS	MREO	TERN	PDSB	HOOK	ELDN	AMLX

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Risk-Adjusted Indicators

There is a big difference between Inozyme Stock performing well and Inozyme Pharma Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Inozyme Pharma's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Treynor Ratio	Potential Upside	Value @Risk	Maximum Drawdown
DAWN	2.87	(0.56)	(0.68)	6.36	(6.67)	22.86
XFOR	6.69	(0.86)	(2.29)	11.67	(14.29)	68.45
ABOS	2.94	(0.66)	(0.60)	6.57	(5.85)	19.77
MREO	2.60	(0.49)	(0.72)	6.16	(6.13)	20.77
TERN	3.01	(1.18)	1.19	4.94	(6.98)	19.13
PDSB	4.66	(0.42)	(0.63)	9.21	(9.22)	33.91
HOOK	3.62	(0.77)	(5.93)	7.00	(7.50)	32.80
ELDN	2.74	(0.24)	(0.24)	4.71	(5.44)	18.63
AMLX	3.70	(0.07)	(0.13)	7.20	(9.09)	21.45

Inozyme Pharma Corporate Management

Henric Bjarke	VP COO	Profile
Gayle Gironda	Senior Officer	Profile
MA MS	Advisor Board	Profile
FASCP MD	Senior Officer	Profile
MSc MBA	President, CoFounder	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC